Neuroprotective effect of AIP on N-methyl-D-aspartate-induced cell death in retinal neurons

A Laabich1, N G Cooper

  • 1Department of Anatomical Sciences and Neurobiology, University of Louisville School of Medicine, 500 S. Preston St., Louisville, KY 40202, USA.

Insights

Calcium/calmodulin-dependent protein kinase II-alpha(B) (CaMKII-alpha(B)) plays a role in N-methyl-D-aspartate (NMDA)-induced neuronal death. Inhibiting CaMKII-alpha(B) with AIP provides neuroprotection against excitotoxicity.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Cell Biology

Background:

  • Excessive glutamate receptor activation leads to neuronal death, but intracellular pathways are not fully understood.
  • Calcium/calmodulin-dependent protein kinase II-alpha(B) (CaMKII-alpha(B)) is altered in retinal neurons exposed to N-methyl-D-aspartate (NMDA).

Purpose of the Study:

  • To investigate the role of CaMKII-alpha(B) in signal transduction pathways leading to NMDA-induced apoptosis.
  • To evaluate the neuroprotective effects of a CaMKII inhibitor against NMDA excitotoxicity.

Main Methods:

  • Terminal deoxyribonucleotidyl transferase (TdT)-mediated biotin-16-dUTP nick-end labelling (TUNEL) assay to detect DNA fragmentation in rat retina.
  • Administration of N-methyl-D-aspartate (NMDA) to induce excitotoxicity.
  • Inhibition of CaMKII activity using myristoylated autocamtide-2-related inhibitory peptide (AIP).
  • Western blot analysis to detect activated caspase-3.

Main Results:

  • NMDA injection caused cell death in the inner nuclear and ganglion cell layers of the rat retina.
  • Complete neuroprotection was achieved with 500 microM AIP administered before and during NMDA application.
  • Partial protection was observed with 100 microM AIP.
  • Activated caspase-3 was detected within 30 minutes to 2 hours post-NMDA injection, and this activation was inhibited by 500 microM AIP.

Conclusions:

  • The CaMKII-alpha(B) isoform is implicated in excitotoxicity-induced neuronal apoptosis.
  • Inhibition of CaMKII activity offers significant neuroprotection against NMDA-induced excitotoxicity.
  • CaMKII-alpha(B) is a potential therapeutic target for conditions involving excitotoxic neuronal death.

Related Concept Videos